Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Probio7 is a prominent UK-based health and wellness company that specializes in the development and distribution of high-quality probiotic supplements. Founded in 1994, the company focuses on supporting the gut microbiome and immune system through scientifically formulated products containing multiple live bacterial strains and prebiotic fibers. Their portfolio includes a variety of specialized supplements such as Probio7 Advanced for daily gut health, Probio7 Bifi for infants, and Probio7 Kids for children's digestive support. The company emphasizes product stability and efficacy, ensuring that their microbial strains remain viable until they reach the gut. Probio7 products are widely available through major retailers and their own e-commerce platform, catering to a broad demographic seeking to improve their digestive wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Probio7.